While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...

Adding external beam radiotherapy did not improve biochemical failure outcomes or prostate cancer specific mortality in ...

Kaiser Permanente Family Medicine Physician Dr. Josh Wilner discusses the steps men can take to detect prostate cancer early.

This is the first time I'm discussing my new PSA blood test results—that's the test that screens for prostate cancer.

For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who ...

Receiving a prostate cancer diagnosis can be life-altering, both mentally and physically. It's a moment filled with ...

Research shows 69 per cent of Black adults are unaware that Black men face a two-fold increased risk of developing prostate ...

Cancer doctors, scientists, and patient advocates said the “cancer” label can do more harm than good, given this form of the ...

Johnson & Johnson reveals Erleada's 23% lower risk of death over Xtandi in a real-world study of prostate cancer patients, ...

Prostate cancer is the most commonly diagnosed cancer in males in 118 of 185 countries, but it's the leading cause of death ...

More than a third of men over the age of 40 have a prostate cancer screening with a PSA test. Still, experts agree it’s unclear if the benefits of the cancer screenings using PSA tests outweigh the ...

Follow-up tests included a prostate MRI, which showed a suspicious spot for cancer on one side of the prostate. An ...